For the latest news and updates, follow us on:

Targeting Intracellular Antigens with pMHC-Binding Antibodies: A Phage Display Approach. 

Phage Display, pages 255-269 (2017)

Authors

Zhihao Wu, Brian H. Santich, Hong Liu, Cheng Liu, Nai-Kong V. Cheung

CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes.

Leukemia 31, 2254–2257. doi:10.1038/leu.2017.223 (2017)

Authors

M D Mathias, J T Sockolosky, A Y Chang, K S Tan, C Liu, K C Garcia & D A Scheinberg

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

Leukemia volume 31, pages 1788–1797. doi:10.1038/leu.2016.373 (2017)

Authors

S Rafiq, T J Purdon, A F DaniyanM KoneruT DaoC LiuD A Scheinberg & R J Brentjens

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

The Journal of Clinical Investigation. doi:110.1172/JCI92335 (2017)

Authors

Aaron Y. Chang, Tao Dao, Ron S. Gejman, Casey A. Jarvis, Andrew Scott,  Leonid Dubrovsky, Melissa D. Mathias, Tatyana Korontsvit, Victoriya Zakhaleva, Michael Curcio, Ronald C. Hendrickson, Cheng Liu, and David A. Scheinberg.

Targeting alpha-fetoprotein (AFP)-MHC complex with CAR T cell therapy for liver cancer.

Clinical Cancer Research. doi:10.1158/1078-0432.CCR-16-1203 (2017)

Authors

Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shon Green, Zhiyuan Yang, Bryan Zimdahl, Jingwei Lu, Neal Cheng, Lucas H Horan, Bin Liu, Sun Yan, Pei Wang, Juan Diaz, Lu Jin,Yoko Nakano, Javier F Morales, Pengbo Zhang, Lian-xing Liu, Binnaz K Staley, Saul J Priceman, Christine E. Brown, Stephen J. Forman, Vivien W Chan, Cheng Liu.

Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.
Journal of Molecular Biology. doi:10.1016/j.jmb.2015.12.002 (2015)

Authors

Ataie N, Xiang J, Cheng N, Brea EJ, Lu W, Scheinberg DA, Liu C, Ng HL.

Generation of TCR-Like Antibodies Using Phage Display.
Methods Molecular Biology. doi: 10.1007/978-1-4939-2999-3_17 (2015)

Authors

Santich BH, Liu H, Liu C, Cheung NK.

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.
Nature Biotechnology. doi: 10.1038/nbt.3349 (2015)

Authors

Tao Dao, Dmitry Pankov, Andrew Scott, Tatyana Korontsvit, Victoriya Zakhaleva, Yiyang Xu, Jingyi Xiang, Su Yan, Manuel Direito de Morais Guerreiro, Nicholas Veomett, Leonid Dubrovsky, Michael Curcio, Ekaterina Doubrovina, Vladimir Ponomarev, Cheng Liu, Richard J O’Reilly & David A Scheinberg.

Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.
Clinical Cancer Research. doi: 10.1158/1078-0432 (2014)

Authors

Veomett N, Dao T, Liu H, Xiang J, Pankov D, Dubrovsky L, Whitten JA, Park SM, Korontsvit T, Zakhaleva V, Casey E, Curcio M, Kharas MG, O’Reilly RJ, Liu C and Scheinberg D.

Real-time cytotoxicity assays in human whole blood.

Authors

Hsiao CW, Lo YT, Liu H, Hsiao SC.

A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias.
Blood. doi: 10.1182 (2014)

Authors

L. Dubrovsky, D. Pankov, E. Joseph Brea, T. Dao, A. Scott, S. Yan, R. J. O’Reilly, C. Liu and D. A. Scheinberg.

Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody.
Sci Transl Med. doi: 10.1126/scitranslmed.3005661

Authors

Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, O’Reilly RJ, Liu C, Scheinberg DA.

Reaching un-drugable intracellular targets with the long arm of antibodies.
Oncotarget. doi: 10.18632/oncotarget.1039 (2013)

Authors

David A. Scheinberg, Tao Dao, Cheng Liu

Approaching untargetable tumor-associated antigens with antibodies.
Oncoimmunology. doi: 10.4161/onci.24678 (2013)

Authors

Dao T, Liu C and Scheinberg DA.

Real Time Assays for Quantifying Cytotoxicity with Single Cell Resolution.
PLoS ONE. Oncoimmunology. 8(6): e66739. doi:10.1371/journal.pone.0066739 (2013)

Authors

Hsiao SC, Liu H, Holstlaw TA, Liu C, Francis CY, et al.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.